ArticlebioRxiv : the preprint server for biology2025
PathX-CNN: An Enhanced Explainable Convolutional Neural Network for Survival Prediction and Pathway Analysis in Glioblastoma.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Motivation: Convolutional neural networks (CNNs) offer potential for analyzing non-grid structured data, such as biological array data, by converting it into image-like formats using principal component analysis (PCA) of pathway genes. However, PCA-derived principal components (PCs) from the entire dataset capture global variance but fail to extract sub-cohort (class-specific) variances. Consequently, CNNs trained on global PCs perform poorly in survival prediction of glioblastoma multiforme (GBM), and the corresponding explanation of CNN outcomes may not align with disease-relevant pathways. Results: We present PathX-CNN, an explainable CNN framework that addresses these limitations by integrating multi-omics data through pathway-based images derived from sub-cohort-specific PCs. PathX-CNN outperformed existing pathway-based methods in predicting long-term survival (LTS) versus non-LTS in GBM. By leveraging SHAP (SHapley Additive exPlanations), a cooperative game theory-based explainable AI method, PathX-CNN identified biologically plausible pathways associated with GBM survival. Additionally, experiments on other cancer types demonstrated superior performance compared to traditional approaches. PathX-CNN demonstrates the potential of CNNs for multi-omics integration, offering both improved prediction accuracy and pathway-specific insights into disease mechanisms.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.